CD8A and neoplasm: Two months after complete tumor regressions and cessation of treatment, the proportion of CD44 + CD62L− effector memory and CD44 + CD62L + central memory CD4 + and CD8 + T cells were higher in the blood of cured mice compared to treatment-naïve mice implanted with tumors (Fig. 4E).